145 related articles for article (PubMed ID: 25779322)
1. Determination of compound kill kinetics against Mycobacterium tuberculosis.
Early J; Alling T
Methods Mol Biol; 2015; 1285():269-79. PubMed ID: 25779322
[TBL] [Abstract][Full Text] [Related]
2. A class of hydrazones are active against non-replicating Mycobacterium tuberculosis.
Bonnett SA; Dennison D; Files M; Bajpai A; Parish T
PLoS One; 2018; 13(10):e0198059. PubMed ID: 30332412
[TBL] [Abstract][Full Text] [Related]
3. A rapid, low pH, nutrient stress, assay to determine the bactericidal activity of compounds against non-replicating Mycobacterium tuberculosis.
Early JV; Mullen S; Parish T
PLoS One; 2019; 14(10):e0222970. PubMed ID: 31589621
[TBL] [Abstract][Full Text] [Related]
4. InhA inhibitors have activity against non-replicating Mycobacterium tuberculosis.
Flint L; Korkegian A; Parish T
PLoS One; 2020; 15(11):e0239354. PubMed ID: 33201882
[TBL] [Abstract][Full Text] [Related]
5. Killing of non-replicating Mycobacterium tuberculosis by 8-hydroxyquinoline.
Darby CM; Nathan CF
J Antimicrob Chemother; 2010 Jul; 65(7):1424-7. PubMed ID: 20435781
[TBL] [Abstract][Full Text] [Related]
6. Bactericidal activity of 2-nitroimidazole against the active replicating stage of Mycobacterium bovis BCG and Mycobacterium tuberculosis with intracellular efficacy in THP-1 macrophages.
Khan A; Sarkar S; Sarkar D
Int J Antimicrob Agents; 2008 Jul; 32(1):40-5. PubMed ID: 18538548
[TBL] [Abstract][Full Text] [Related]
7. Enhancement of in vitro activity of tuberculosis drugs by addition of thioridazine is not reflected by improved in vivo therapeutic efficacy.
de Knegt GJ; ten Kate MT; van Soolingen D; Aarnoutse R; Boeree MJ; Bakker-Woudenberg IA; de Steenwinkel JE
Tuberculosis (Edinb); 2014 Dec; 94(6):701-7. PubMed ID: 25621361
[TBL] [Abstract][Full Text] [Related]
8. Antimycobacterial activity of econazole against multidrug-resistant strains of Mycobacterium tuberculosis.
Ahmad Z; Sharma S; Khuller GK; Singh P; Faujdar J; Katoch VM
Int J Antimicrob Agents; 2006 Dec; 28(6):543-4. PubMed ID: 17101262
[TBL] [Abstract][Full Text] [Related]
9. Resazurin reduction assays for screening of anti-tubercular compounds against dormant and actively growing Mycobacterium tuberculosis, Mycobacterium bovis BCG and Mycobacterium smegmatis.
Taneja NK; Tyagi JS
J Antimicrob Chemother; 2007 Aug; 60(2):288-93. PubMed ID: 17586560
[TBL] [Abstract][Full Text] [Related]
10. Effects of low incubation temperatures on the bactericidal activity of anti-tuberculosis drugs.
Coleman D; Waddell SJ; Mitchison DA
J Antimicrob Chemother; 2011 Jan; 66(1):146-50. PubMed ID: 21071459
[TBL] [Abstract][Full Text] [Related]
11. [Determining dehydrogenase activity as a method of accelerated indication of the viability of Mycobacterium tuberculosis].
Vishnevskiĭ BI; Manicheva OA
Probl Tuberk; 1992; (7-8):42-4. PubMed ID: 1488441
[TBL] [Abstract][Full Text] [Related]
12. Microplate Alamar Blue Assay (MABA) and Low Oxygen Recovery Assay (LORA) for Mycobacterium tuberculosis.
Cho S; Lee HS; Franzblau S
Methods Mol Biol; 2015; 1285():281-92. PubMed ID: 25779323
[TBL] [Abstract][Full Text] [Related]
13. Benzimidazole-based compounds kill Mycobacterium tuberculosis.
Gong Y; Somersan Karakaya S; Guo X; Zheng P; Gold B; Ma Y; Little D; Roberts J; Warrier T; Jiang X; Pingle M; Nathan CF; Liu G
Eur J Med Chem; 2014 Mar; 75():336-53. PubMed ID: 24556148
[TBL] [Abstract][Full Text] [Related]
14. Minimum Bactericidal Concentration Techniques in
Santos NCS; Scodro RBL; Sampiron EG; Ieque AL; Carvalho HC; Santos TDS; Ghiraldi Lopes LD; Campanerut-Sá PAZ; Siqueira VLD; Caleffi-Ferracioli KR; Teixeira JJV; Cardoso RF
Microb Drug Resist; 2020 Jul; 26(7):752-765. PubMed ID: 31977277
[TBL] [Abstract][Full Text] [Related]
15. Activity of trifluoperazine against replicating, non-replicating and drug resistant M. tuberculosis.
Advani MJ; Siddiqui I; Sharma P; Reddy H
PLoS One; 2012; 7(8):e44245. PubMed ID: 22952939
[TBL] [Abstract][Full Text] [Related]
16. Rapid, Semiquantitative Assay To Discriminate among Compounds with Activity against Replicating or Nonreplicating Mycobacterium tuberculosis.
Gold B; Roberts J; Ling Y; Quezada LL; Glasheen J; Ballinger E; Somersan-Karakaya S; Warrier T; Warren JD; Nathan C
Antimicrob Agents Chemother; 2015 Oct; 59(10):6521-38. PubMed ID: 26239979
[TBL] [Abstract][Full Text] [Related]
17. Application of Continuous Culture for Assessing Antibiotic Activity Against Mycobacterium tuberculosis.
Hendon-Dunn CL; Anwar S; Burton C; Bacon J
Methods Mol Biol; 2018; 1736():59-73. PubMed ID: 29322459
[TBL] [Abstract][Full Text] [Related]
18. 8-Hydroxyquinolines are bactericidal against Mycobacterium tuberculosis.
Odingo JO; Early JV; Smith J; Johnson J; Bailey MA; Files M; Guzman J; Ollinger J; Korkegian A; Kumar A; Ovechkina Y; Parish T
Drug Dev Res; 2019 Aug; 80(5):566-572. PubMed ID: 30893501
[TBL] [Abstract][Full Text] [Related]
19. Targeting human macrophages for enhanced killing of intracellular XDR-TB and MDR-TB.
Martins M; Viveiros M; Couto I; Amaral L
Int J Tuberc Lung Dis; 2009 May; 13(5):569-73. PubMed ID: 19383188
[TBL] [Abstract][Full Text] [Related]
20. Evaluation of killing kinetics of anti-tuberculosis drugs on Mycobacterium tuberculosis using a bacteriophage-based assay.
Marcel N; Nahta A; Balganesh M
Chemotherapy; 2008; 54(5):404-11. PubMed ID: 18772589
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
